Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On December 20, 2021, Amgen announced the FDA approval of Otezla (apremilast), for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
Return to publications